David Fitz-Patrick MD

Endocrinology•Honolulu, HI

Diabetes, Parathyroid, Pituitary Disorders & Neuroendocrinology, Thyroid

Physician

Join to View Full Profile

1585 Kapiolani BlvdSuite 1500Honolulu, HI 96814
Phone+1 808-531-6886
Fax+1 808-523-5115

Education & Training

University of MarylandResidency, Internal Medicine, 1975 - 1977
University of Newcastle Upon Tyne Faculty of MedicineClass of 1974

Certifications & Licensure

HI State Medical License 1981 - 2026
MD State Medical License 1976 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
Terminated
Phase 2
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
Completed
Phase 2
A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device Start of enrollment: 2014 Jun 01
Completed
Phase 1
A Study of LY2623091 in Participants With High Blood Pressure Start of enrollment: 2014 Aug 01
Completed
Phase 2
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Terminated
Phase 3
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Completed
Phase 2
Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles Start of enrollment: 2019 Feb 07
Completed
Not Applicable
A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath Start of enrollment: 2021 Jun 23
Active, not recruiting
Phase 1
Roles: Contact
A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
ACTIVE_NOT_RECRUITING
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial.
David Fitz-Patrick, Hanako Mihara, Anthony Mills, Runa Mithani, Archana Kapoor
Respiratory Investigation. 2024-11-01
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Dia...
Elena A Christofides, Andrzej Stankiewicz, Douglas Denham, Diego Bellido, Edward Franek
Endocrine Practice. 2024-09-01
2 citations
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 di...
Elena A Christofides, Orlando Puente, Paul Norwood, Douglas Denham, Hiralal Maheshwari
Diabetes, Obesity & Metabolism. 2024-06-01